company_defendants	text
Juniper Networks, Inc.	" 
14. Plaintiff, as set forth in the attached cer tification, purchased J uniper securities at 
artificially inflated prices dur ing the Class Period and has been damaged upon the revelation of the 
alleged corrective disclosure.  
15. Defendant Juniper is a Delaware corporation with its headquarters located at 1194 North 
Mathilda Avenue, Sunnyvale, CA 94089.  The commo n stock is traded on the New York Stock 
Exchange (“NYSE”) under the ticker symbol “JNPR.” 
16. Defendant Kevin R. Johnson (“Johnson”) has served as the Company’s Chief Executive 
Officer throughout the Class Period. 
17. Defendant Pradeep S. Sindhu (“Sindhu”) is  the Company’s Vice Chairman, Chief 
Technology Officer and Founder. Defendant Sindhu sold 300,000 shares of the Company’s stock on 
August 2, 2013, less than a week before the FCPA investigation was announced, and also sold 52,500 
Juniper shares over three trad ing sessions between January 30, 2013 through February 1, 2013.  
18. Defendant Robyn M. Denholm (“Denholm”) ha s served as the Company’s Executive 
Vice President and Chief Financial O fficer throughout the Class Period. 
19. Defendant Gene Zamiska (“Zamiska”) has se rved as the Company’s Vice President, 
Finance throughout the Class Period.  Defendant Zamiska served as the Company’s Corporate 
Controller through February 26, 2013. 
20. The defendants referenced above in ¶¶ 15 – 18 are sometimes referred to herein as the 
“Individual Defendants.”  Case3:13-cv-03733-WHO   Document1   Filed08/12/13   Page4 of 20 
COMPLAINT FOR VIOLATIONS OF THE FEDERAL SECURITIES LAWS 
4 1 
2 3 4 5 6 
7 
8 9 
10 11 12 
13 
14 15 16 17 18 
19 
20 21 22 23 24 
25 
26 27 28 "
Electronic Arts Inc.	"	
10 	11. 	Plaintiff Ryan Kelly purchased Electronic Arts common stock during the Class Period 
11 as described in the Certification attached hereto and incorporated herein by reference and suffered 
12 damages thereon. 	
13 	12. 	Defendant Electronic Arts, headquartered in Redwood City, California, develops, 
14 markets, publishes and distributes game software content and services. During the Class Period, 
15 Electronic Arts had more than 309 million shares of common stock outstanding, which shares traded 
16 in an efficient market on the NASDAQ under the ticker symbol ""EA."" Electronic Arts was followed 
17 by scores of stock analysts and stock rating agencies and was constantly in communication with the 
18 markets and investors in quarterly conference calls and frequent presentations to investor and analyst 
19 conferences. Electronic Arts also filed periodic public reports with the SEC, and regularly issued 
20 press releases to the financial press. 	
21 	13. 	Defendant Andrew Wilson (""Wilson"") is, and was throughout the Class Period, an 
22 executive of Electronic Arts, assuming the position of its Chief Executive Officer (""CEO"") and a 
23 director of the Company effective September 15, 2013. 	
24 	14. 	Defendant Blake J. Jorgensen (""Jorgensen"") is, and was throughout the Class Period, 
25 I Electronic Arts' Chief Financial Officer and an Executive Vice President. 	
26 	15. 	Defendant Frank D. Gibeau (""Gibeau"") is, and was throughout the Class Period, 
27 President of the EA Labels. 
28 
COMPLAINT FOR VIOLATIONS OF THE FEDERAL SECURITIES LAWS Case3:13-cv-05837   Document1   Filed12/17/13   Page5 of 251 
2 
3 
4 
5 
6 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
All 
21 
22 
23 
24 
25 
26 
27 
28 16. Defendant Patrick Soderlund (""Soderlund"") is, and was throughout the Class Period, 
I Executive Vice President of the EA Games Label. 
17. Defendant Peter Robert Moore (""Moore"") is, and was throughout the Class Period, 
I Electronic Arts' President and Chief Ope"
Catalyst Pharmaceutical Partners, Inc.	"
11. Plaintiff, as set forth in th e attached certification, purchas ed Catalyst securities at 
artificially inflated prices dur ing the Class Period and has b een damaged upon the revelation of 
the alleged corrective disclosures. 
12.  Defendant Catalyst is a Coral Gates, Florida headquartered company located at 
355 Alhambra Circle Suite 1500 Coral Gates, FL 33134. The common stock is traded on the 
NASDAQ Stock Market (""NASDAQ"") unde r the ticker symbol ""CPRX."" 
13. Defendant Patrick J. McEnany (""McEna ny"") is the Company’s co-founder, CEO 
and President. 
14.  Defendant Dr. Hubert E. Huckel M.D.  (""Huckel"") is the Company’s co-founder 
and one of its directors. 
15. Defendant Steven R. Miller Ph. D. (""M iller"") is the company’s COO and CSO. 
16.  The defendants referenced above in ¶¶ 13- 15 are sometimes referred to herein as 
the ""Individual Defendants."" 
DEFENDANTS' WRONGDOING 
 
Background 
 Case 1:13-cv-23878-UU   Document 1   Entered on FLSD Docket 10/25/2013   Page 4 of 20 
5 17. Catalyst is a specialty pharmaceutical company which develops and 
commercializes drugs treating orphan (rare) neuromuscular an d neurological diseases. 
18. Lambert-Eaton Myasthenic Syndrome (“LEM S”) is an extremely serious disase 
which is also extremely rare, afflicting about 3.4 persons per million, and about one to two thousand patients in the United States. 
19. FDA rules permit so-called “compassionate use” – use of a drug that has not been 
approved by the FDA outside of clinical trials. A patient may be given drugs under a 
compassionate use program if the patient may benefit from the treatment, the therapy can be 
given safely outside the clinical trial setting, no other alternative therapy is available, and the 
drug developer agrees to provide access to the drug. 
20. Jacobus is a tiny privat e pharmaceutical company in  New Jersey, with only 
dozens of employees, and only 35 as of 2009. Jacobus has b een manufacturing 3,4 DAP and 
providing it to patients through a "
